Vaccinations
464 results
1 - 100
Vaccines for preventing rotavirus diarrhoea: vaccines in use- Vaccines for preventing smallpox
- Vaccines for preventing anthrax
- Vaccines for the common cold
- Pneumococcal vaccine for asthma
- Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)
- Vaccines for preventing typhoid fever
- Rotavirus vaccine for preventing diarrhoea
- Pneumococcal vaccines for cystic fibrosis
- Oral vaccines for preventing cholera
- Vaccines for preventing Japanese encephalitis
- Vaccines for preventing influenza in the elderly
- Vaccines for preventing malaria (SPf66)
- Vaccination for preventing postherpetic neuralgia
- Vaccines for preventing influenza in people with asthma
- Influenza vaccines in immunosuppressed adults with cancer
- Improving vaccination uptake among adolescents
- Vaccines for preventing influenza in healthy adults
- Vaccines for preventing malaria (pre‐erythrocytic)
- Vaccines for preventing influenza in healthy children
- Pneumococcal vaccines for children and adults with bronchiectasis
- Influenza vaccines for preventing cardiovascular disease
- Vaccines for preventing influenza in people with cystic fibrosis
- Vaccines for preventing malaria (blood‐stage)
- Vaccines for preventing tick‐borne encephalitis
- Acellular vaccines for preventing whooping cough in children
- Needle size for vaccination procedures in children and adolescents
- Booster dose vaccination for preventing hepatitis B
- Oral killed cholera vaccines for preventing cholera
- Efficacy and safety of COVID‐19 vaccines
- Influenza vaccine for children and adults with bronchiectasis
- Vaccines for measles, mumps, rubella, and varicella in children
- Vaccines for preventing infections in adults with solid tumours
- Vaccines for preventing infections in adults with haematological malignancies
- Vaccines for preventing plague: Cochrane systematic review
- Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea
- Vaccines for preventing herpes zoster in older adults
- Vaccines for preventing hepatitis B in health‐care workers
- Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV‐related disease and harms from vaccination
- Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
- Influenza vaccine for chronic obstructive pulmonary disease (COPD)
- Interventions to improve vaccination uptake among adults
- Pneumococcal vaccination during pregnancy for preventing infant infection
- MVA85A vaccine to enhance BCG for preventing tuberculosis
- Vaccines for preventing pneumococcal infection in adults
- Nicotine vaccines for smoking cessation: Cochrane systematic review
- Vaccines for preventing Ebola virus disease
- Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
- Conjugate Haemophilus influenzae type b vaccines for sickle cell disease
- Interventions aimed at communities to inform and/or educate about early childhood vaccination
- Influenza vaccines for preventing acute otitis media in infants and children
- Vaccines for women for preventing neonatal tetanus
- Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection
- Vaccines for preventing invasive salmonella infections in people with sickle cell disease
- Typhoid conjugate vaccines for preventing typhoid fever (enteric fever)
- Therapeutic vaccines for advanced non‐small cell lung cancer
- Pneumococcal conjugate vaccines for preventing acute otitis media in children
- Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
- Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes
- Pneumococcal vaccines for sickle cell disease: Cochrane systematic review
- Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia in children less than two years of age
- Influenza vaccination in children being treated with chemotherapy for cancer: Cochrane systematic review
- Face‐to‐face interventions for informing or educating parents about early childhood vaccination
- Vaccines for prophylaxis of viral infections in patients with hematological malignancies: Cochrane systematic review
- Interventions to increase COVID‐19 vaccine uptake: a scoping review
- Interventions to increase influenza vaccination rates of those 60 years and older in the community
- Hepatitis B vaccination for patients with chronic renal failure: Cochrane systematic review
- Conjugate vaccines for preventing meningococcal C meningitis and septicaemia: Cochrane systematic review
- Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis
- Whole‐cell pertussis vaccine in early infancy for the prevention of allergy in children
- Polysaccharide vaccines for preventing serogroup A meningococcal meningitis: Cochrane systematic review
- Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB): Cochrane systematic review
- Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults
- Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
- Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence
- Conjugate vaccines for preventing Haemophilus influenzae type B infections: Cochrane systematic review
- Hepatitis B vaccination during pregnancy for preventing infant infection: Cochrane systematic review
- Yellow fever vaccine for patients with HIV infection: Cochrane systematic review
- Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis
- COVID‐19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies
- Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis
- Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
- Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults: Cochrane systematic review
- Healthcare workers’ perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis
- Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males
- Factors that influence caregivers’ and adolescents’ views and practices regarding human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence synthesis
- Influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐term care institutions
- Pneumococcal conjugate vaccines for preventing invasive pneumococcal disease and pneumonia in children aged up to five years
- Adults' views and experiences of vaccines developed in response to the COVID‐19 pandemic: a qualitative evidence synthesis
- Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis: Cochrane systematic review
- Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis
- Immunity after COVID‐19 vaccination in people with higher risk of compromised immune status: a scoping review
- Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV‐related diseases: a network meta‐analysis
- Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes: Cochrane systematic review
- Hepatitis A immunisation in persons not previously exposed to hepatitis A